METTL14 Aggravates Sepsis‐Induced Acute Kidney Injury by Promoting Ferroptosis Through m6A Modification of BMAL1
Clinical and Experimental Pharmacology and Physiology · 2026-03 · 53 (3)
DOI: 10.1111/1440-1681.70107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 08.03.2026. Verfasst von Yishu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comprehensive Internal Medicine, Beijing Xiaotangshan Hospital, Beijing, China. Hauptthemen laut MEDLINE: Sepsis, ARNTL Transcription Factors, Acute Kidney Injury, Methyltransferases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a common and severe complication of sepsis and represents an independent risk factor for mortality in septic patients. Despite its clinical significance, the mechanisms of sepsis‐induced AKI (Sepsis‐AKI) remain incompletely understood. This study investigates the role of methyltransferase like 14 (METTL14)‐mediated m6A modification in regulating brain and muscle ARNT‐like protein‐1 (BMAL1) stability and its effect on tubular epithelial cell injury and ferroptosis.
Methods
Human renal proximal tubular epithelial (HK‐2) cells were treated with lipopolysaccharide (LPS) to establish an in vitro model of Sepsis‐AKI. Cell proliferation and viability were assessed using EdU and CCK‐8 assays; apoptosis was evaluated by TUNEL staining, and inflammatory cytokines Interleukin‐6 (IL‐6) and IL‐1β were measured by ELISA. Ferroptosis indices were detected using corresponding kits. RT‐qPCR and Western blotting were used to detect mRNA and protein expression. MeRIP and RIP assays were used to evaluate BMAL1 m6A modification and RNA‐protein interaction. The stability of BMAL1 mRNA was determined using an Actinomycin D chase assay. A Sepsis‐AKI model was established to examine the effect of METTL14 silencing on renal injury.
Results
BMAL1 overexpression significantly alleviated LPS‐induced apoptosis, inflammatory responses, and ferroptosis in HK‐2 cells. Furthermore, METTL14 silencing reduced BMAL1 m6A modification, stabilized BMAL1 mRNA, and consequently improved HK‐2 cell injury. In addition, YTHN6‐methyladenosine RNA binding protein 1 (YTHDF1) was identified as the critical m6A reader mediating BMAL1 mRNA degradation. Consistently, in vivo experiments demonstrated that METTL14 knockdown mitigated Sepsis‐AKI and ferroptosis in mice.
Conclusion
METTL14 enhanced BMAL1 m6A modification and promoted YTHDF1‐mediated BMAL1 degradation, thereby facilitating ferroptosis and aggravating Sepsis‐AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Comprehensive Internal Medicine, Beijing Xiaotangshan Hospital, Beijing, China.
- Department of Nephrology, China-Japan Friendship Hospital, Beijing, China.
ORCID-Profile: Haifeng Wang
Zitieren
APA
Wang, Y., Li, Y., Wu, N., Xu, X., Fan, X., & Wang, H. (2026). METTL14 Aggravates Sepsis‐Induced Acute Kidney Injury by Promoting Ferroptosis Through m6A Modification of BMAL1. Clinical and Experimental Pharmacology and Physiology, 53(3). https://doi.org/10.1111/1440-1681.70107
Vancouver
Wang Y, Li Y, Wu N, Xu X, Fan X, Wang H. METTL14 Aggravates Sepsis‐Induced Acute Kidney Injury by Promoting Ferroptosis Through m6A Modification of BMAL1. Clinical and Experimental Pharmacology and Physiology. 2026;53(3). doi:10.1111/1440-1681.70107
BibTeX
@article{Wang2026,
author = {Wang, Yishu and Li, Yang and Wu, Na and Xu, Xinyue and Fan, Xiaoxuan and Wang, Haifeng},
title = {METTL14 Aggravates Sepsis‐Induced Acute Kidney Injury by Promoting Ferroptosis Through m6A Modification of BMAL1},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2026},
volume = {53},
number = {3},
doi = {10.1111/1440-1681.70107}
}
EUVIMED